Women's Health: Society of Internal Medicine Calls for More Basic Research - Germany's medical research fails women—will new promises close the gap?

Calls for stronger gender-sensitive medical research are growing in Germany. The German Society for Internal Medicine (DGIM) has urged the federal government to prioritise women's health insurance studies. Ministers have responded with promises but have yet to announce specific plans.

DGIM President Dagmar Führer-Sakel highlighted a persistent issue: most clinical trials focus on male subjects. Results from these studies are then applied to women without accounting for biological differences. She pointed out that many medical fields still lack gender-sensitive approaches.

No clear data exists on how many women and men took part in Germany's major clinical trials over the past five years. Reports confirm a Gender Data Gap, stressing the need for more inclusive health insurance research. However, no exact figures have been provided to show the imbalance.

Research Minister Dorothee Bär (CSU) and Health Minister Nina Warken (CDU) have both pledged support for gender-sensitive medical research. So far, though, they have not detailed how this will be implemented.

The push for better gender representation in medical studies continues. Without concrete steps, the gap in health insurance research data remains unaddressed. The government's next moves will determine whether women's health insurance receives the attention experts demand.